Changes to the website
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4891

Previous 25           Next 25
Website Changes
09/14/2019 DeAngelis named MSK physician-in-chief, chief medical officer
09/13/2019 Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
09/11/2019 Frankly Speaking About Brain Tumors
09/11/2019 Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
09/09/2019 Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer
09/09/2019 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting
08/30/2019 Musella Foundation awards a pediatric brain tumor research grant!
08/15/2019 DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
08/15/2019 Attend an Optune Open House
08/03/2019 Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.
08/03/2019 Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
07/29/2019 Valerie Harper to stay out of hospice care, husband says
07/29/2019 Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.
07/29/2019 Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
07/26/2019 Musella Foundation Brain Tumor Copay Program has reopened!
07/20/2019 A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
07/19/2019 Study hints at why an aggressive form of brain cancer is hard to treat
07/19/2019 A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
07/18/2019 Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma
07/17/2019 ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company
07/17/2019 Electricity helps control man’s brain tumor
07/16/2019 GBM Awareness Day This Wednesday July 17th!
07/16/2019 Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma
07/16/2019 Attend an Optune Open House.
07/15/2019 Phase II study of Dovitinib in recurrent glioblastoma.

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557